Effect of neurofibromatosis type I mutations on a novel pathway for adenylyl cyclase activation requiring neurofibromin and Ras

Human Molecular Genetics
Frances HannanYi Zhong

Abstract

Neurofibromatosis type I (NFI) is a common genetic disorder that causes nervous system tumors, and learning and memory defects in humans, and animal models. We identify a novel growth factor stimulated adenylyl cyclase (AC) pathway in the Drosophila brain, which is disrupted by mutations in the epidermal growth factor receptor (EGFR), neurofibromin (NF1) and Ras, but not Galpha(s). This is the first demonstration in a metazoan that a receptor tyrosine kinase (RTK) pathway, acting independently of the heterotrimeric G-protein subunit Galpha(s), can activate AC. We also show that Galpha(s) is the major Galpha isoform in fly brains, and define a second AC pathway stimulated by serotonin and histamine requiring NF1 and Galpha(s), as well as a third, classical Galpha(s)-dependent AC pathway, which is stimulated by Phe-Met-Arg-Phe-amide (FMRFamide) and dopamine. Using mutations and deletions of the human NF1 protein (hNF1) expressed in Nf1 mutant flies, we show that Ras activation by hNF1 is essential for growth factor stimulation of AC activity. Further, we demonstrate that sequences in the C-terminal region of hNF1 are sufficient for NF1/Galpha(s)-dependent neurotransmitter stimulated AC activity, and for rescue of body size defect...Continue Reading

References

Jan 1, 1985·Cold Spring Harbor Symposia on Quantitative Biology·C BirchmeierM Wigler
Sep 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·M S Livingstone
Oct 22, 1982·Science·G M Rubin, A C Spradling
Jan 1, 1993·Annual Review of Neuroscience·D ViskochilR Cawthon
Jul 21, 1998·Human Molecular Genetics·A KloseP Nürnberg
Sep 8, 1998·Current Opinion in Genetics & Development·C Rommel, E Hafen
Nov 11, 1999·Archives of Neurology·D H Gutmann
Mar 10, 2001·Cell·K Cichowski, T Jacks
May 23, 2001·Current Biology : CB·S Bogdan, C Klämbt
Jul 17, 2001·Genetics·W J WolfgangM Forte
Jan 15, 2002·Nature Neuroscience·Jiayuan TongYi Zhong
Jul 10, 2002·Progress in Nucleic Acid Research and Molecular Biology·Lawrence A QuilliamAriel F Castro
Aug 3, 2002·Nature Reviews. Cancer·Yuan Zhu, Luis F Parada
Jan 14, 2003·Trends in Molecular Medicine·Rui M Costa, Alcino J Silva
Mar 22, 2003·Experimental Cell Research·Robert N JorissenAntony W Burgess
Mar 3, 2004·Molecular Interventions·Roger K Sunahara, Ron Taussig

❮ Previous
Next ❯

Citations

Mar 21, 2007·Journal of Biomedical Science·Yi-Ping Hsueh
Mar 31, 2010·Proceedings of the National Academy of Sciences of the United States of America·Hsueh-Cheng ChiangYi Zhong
Sep 1, 2007·Antioxidants & Redox Signaling·Ronald C Wek, Douglas R Cavener
Jul 11, 2008·Human Molecular Genetics·Balazs HegedusDavid H Gutmann
Mar 30, 2010·Annual Review of Neuroscience·C ShilyanskyA J Silva
Nov 28, 2007·Annual Review of Pathology·Andrea I McClatchey
Nov 23, 2011·The Journal of Clinical Investigation·Hsiao-Fang WangYi-Ping Hsueh
Jul 30, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Monica E Buchanan, Ronald L Davis
Oct 12, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·David H GutmannNancy Ratner
Jan 15, 2014·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Salma Ben-SalemLihadh Al-Gazali
Jul 30, 2014·Human Molecular Genetics·Corina Anastasaki, David H Gutmann
Nov 18, 2008·Journal of Neurogenetics·Chia-Lin Wu, Ann-Shyn Chiang
Aug 28, 2014·Expert Review of Neurotherapeutics·Katherine E Schwetye, David H Gutmann
Aug 27, 2013·Journal of the American Academy of Dermatology·Myriam MarqueDidier Bessis
Jan 15, 2013·Trends in Neurosciences·Kelly A Diggs-Andrews, David H Gutmann
Sep 10, 2011·Molecular and Cellular Neurosciences·Jacquelyn A BrownDavid H Gutmann
Mar 18, 2008·Biochemical and Biophysical Research Communications·Shixing ZhangAike Guo
Mar 28, 2007·Annals of Neurology·Robert ListernickDavid H Gutmann
Jul 4, 2006·Clinical Genetics·A B Trovó-Marqui, E H Tajara
Dec 12, 2012·Annals of Neurology·Kelly A Diggs-AndrewsDavid H Gutmann
Nov 9, 2010·Dermatologic Therapy·Ana Maria Abreu Velez, Michael S Howard
Mar 4, 2008·Biochemical and Biophysical Research Communications·Yi-Ling Lin, Yi-Ping Hsueh
Jun 20, 2015·Frontiers in Psychiatry·Alaura AndroschukFrancois V Bolduc
Jun 9, 2016·Free Radical Biology & Medicine·Waylan K BesslerBrian K Stansfield
Oct 30, 2016·Proceedings of the National Academy of Sciences of the United States of America·Wissem Deraredj NadimSéverine Morisset-Lopez
Mar 30, 2007·Nature Genetics·James A Walker, André Bernards
Nov 14, 2019·Cellular and Molecular Neurobiology·Mu-Wen ChenYu Qiu
Jan 8, 2020·Cancers·Mina LobbousLouis B Nabors
Oct 22, 2016·PLoS Genetics·Annekathrin WidmannAndreas S Thum
Feb 21, 2016·G3 : Genes - Genomes - Genetics·Lanikea B KingSeth M Tomchik
Oct 31, 2020·Cells·Mohammed BergougHélène Bénédetti
Jul 24, 2015·Disease Models & Mechanisms·Granton A JindalStanislav Y Shvartsman
Mar 21, 2013·Learning & Memory·Tasja RahnHenning Fedders

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.